Principal Financial Group Inc. Has $8.47 Million Position in Eastman Chemical Company $EMN

Principal Financial Group Inc. lessened its stake in shares of Eastman Chemical Company (NYSE:EMNFree Report) by 8.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 134,270 shares of the basic materials company’s stock after selling 12,264 shares during the period. Principal Financial Group Inc.’s holdings in Eastman Chemical were worth $8,466,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Norges Bank acquired a new position in Eastman Chemical in the 2nd quarter valued at $121,060,000. Allspring Global Investments Holdings LLC grew its position in shares of Eastman Chemical by 1,011.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 943,975 shares of the basic materials company’s stock valued at $58,489,000 after purchasing an additional 859,046 shares during the last quarter. Qube Research & Technologies Ltd increased its stake in shares of Eastman Chemical by 1,456.4% in the second quarter. Qube Research & Technologies Ltd now owns 708,290 shares of the basic materials company’s stock worth $52,881,000 after purchasing an additional 662,783 shares during the period. Ilex Capital Partners UK LLP acquired a new position in shares of Eastman Chemical during the 2nd quarter worth about $42,547,000. Finally, First Trust Advisors LP boosted its stake in Eastman Chemical by 96.7% during the 2nd quarter. First Trust Advisors LP now owns 438,804 shares of the basic materials company’s stock valued at $32,761,000 after purchasing an additional 215,679 shares during the period. 83.65% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Eastman Chemical

Here are the key news stories impacting Eastman Chemical this week:

  • Positive Sentiment: Board announced a quarterly dividend of $0.84 per share (record Mar 13, payable Apr 8), implying about a 4.2% yield — supports income investors and can underpin the share price.
  • Positive Sentiment: Significant insider buying: multiple executives (including CEO Mark Costa) purchased shares in the past six months, which investors often read as management confidence in the business.
  • Positive Sentiment: Large institutional buying: BlackRock added ~5.75M shares (+72%) in Q4 2025 — heavy buying from a major fund can provide price support and liquidity.
  • Neutral Sentiment: Analyst coverage is mixed-but-tilted-positive: several firms carry Buy/Overweight ratings (KeyBanc, Citi, UBS, Wells Fargo), but price targets vary and the median target (~$72.50) is below recent trading levels, signalling differing views on near-term upside/ downside.
  • Negative Sentiment: Q4 2025 results were weak: revenue $1.97B (down ~12% YoY), gross profit and operating profit plunged, net income fell ~68% YoY and diluted EPS declined ~67% YoY to $0.92. Cash and cash equivalents declined ~32% YoY to $566M. These marked declines help explain downside pressure on the stock. Q4 2025 Earnings
  • Negative Sentiment: Zacks Research has trimmed multiple near‑term and multi‑year EPS forecasts (FY2026 cut to $5.89, FY2027 to $6.73) and reduced several quarterly estimates — lowers Street expectations and could lead to renewed analyst target/ guidance pressure.

Eastman Chemical Trading Up 0.2%

Shares of EMN opened at $79.97 on Friday. The stock has a fifty day moving average price of $68.40 and a two-hundred day moving average price of $65.17. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.86 and a current ratio of 1.76. The company has a market cap of $9.12 billion, a price-to-earnings ratio of 19.55, a PEG ratio of 1.76 and a beta of 1.23. Eastman Chemical Company has a 52-week low of $56.11 and a 52-week high of $103.82.

Eastman Chemical (NYSE:EMNGet Free Report) last announced its earnings results on Thursday, January 29th. The basic materials company reported $0.75 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.01). Eastman Chemical had a return on equity of 10.63% and a net margin of 5.42%.The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $2.03 billion. During the same period in the prior year, the firm posted $1.87 earnings per share. The company’s revenue was down 12.1% on a year-over-year basis. Analysts predict that Eastman Chemical Company will post 8.55 EPS for the current fiscal year.

Eastman Chemical Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Friday, March 13th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 4.2%. The ex-dividend date is Friday, March 13th. Eastman Chemical’s dividend payout ratio (DPR) is presently 82.15%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on EMN shares. KeyCorp reiterated an “overweight” rating on shares of Eastman Chemical in a report on Monday, February 2nd. Weiss Ratings cut shares of Eastman Chemical from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, February 4th. Evercore decreased their price target on shares of Eastman Chemical from $75.00 to $70.00 and set an “in-line” rating on the stock in a research report on Tuesday, November 11th. UBS Group cut their price objective on shares of Eastman Chemical from $75.00 to $73.00 and set a “buy” rating for the company in a research report on Wednesday, November 5th. Finally, Citigroup lifted their target price on Eastman Chemical from $75.00 to $78.00 and gave the stock a “buy” rating in a research report on Tuesday, February 3rd. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $78.86.

Check Out Our Latest Stock Report on Eastman Chemical

Eastman Chemical Company Profile

(Free Report)

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.

Read More

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical Company (NYSE:EMNFree Report).

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.